Former Zenith Vice Chairman and Chief Operating Officer Ken Larsen is returning to Warner-Lambert to head the company's newly formed generic unit. Larsen was with W-L for over 25 years prior to heading Zenith operations. He resigned from Zenith in November 1984 after six years with the firm. He also served on the board of the Generic Pharmaceutical Industry Association.
You may also be interested in...
Splitting Colfax into separate fabrication technology and specialty medical technology businesses will help both sides of the business grow, CEO Matthew Trerotola said recently.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.
Use of per- and polyfluoroalkyl substances in cosmetic products appears to be declining, based on voluntary industry registrations with the US Food and Drug Administration. In any event, NGOs are gunning for PFAS' elimination, and the FDA says available data have yet to give a complete safety picture for PFAS used intentionally in cosmetics or present as impurities.